Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

COVID-19 and Metabolic Syndrome: NF-κB Activation. Crossroads

2020; Elsevier BV; Volume: 31; Issue: 11 Linguagem: Inglês

10.1016/j.tem.2020.08.004

ISSN

1879-3061

Autores

Pablo Guisado‐Vasco, Marta Cano-Megías, Margarita Rodríguez-López, Iris Mercedes de-Luna-Boquera, Daniel Carnevali-Ruiz,

Tópico(s)

Phagocytosis and Immune Regulation

Resumo

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in December 2019 as the cause of severe pneumonia in a cluster of patients in Wuhan, China. Subsequently, this viral pathogen was described as a novel RNA betacoronavirus [1]. As with other members of its group, SARS-CoV-2 is able to cause a severe acute respiratory syndrome, in this case named coronavirus disease 2019 (COVID-19).

Referência(s)